Tags: Drug.

Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer.This drug was developed by Immunomedics Inc.

ATC prefix
none
CAS number
219649-07-7

Loading...

This page contains content from the copyrighted Wikipedia article "Labetuzumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.